MGK_2: "The holistic teamwork that translational research relies upon is something at which amfAR has excelled, so it’s no surprise that Dr. Ndhlovu was recently chosen to helm its Scientific Advisory Committee, a volunteer group of leading researchers who review grant applications and guide the foundation’s research program. (Dr. Ndhlovu also serves on the Board of Directors and has equity with CytoDyn, Inc., a company that is developing therapeutics to treat HIV.)"

His position to Nov. 11th, 2025.

I tried replying this to your outstanding post from today, but giving me password issues.

In the past, we were supposedly in talks with amFAR, Thai Red Cross & US Army for funding.

Now we see our Cytodyn connect @ a very prominent role @ amFAR.

MGK's outstanding post...
( click the blue Reddit link in Cytomights comment, for anyone reading here that dosen't know )

https://stocktwits.com/Cytomight/message/580910994

Thx again!!